Literature DB >> 24861984

Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals.

Dong Zhou1, Mai Lin, Norio Yasui, Mohammed H Al-Qahtani, Carmen S Dence, Sally Schwarz, John A Katzenellenbogen.   

Abstract

Fluorine-18-labeled steroid receptor tracers, 16α-[(18)F]fluoroestradiol (FES), [(18)F]fluoro furanyl norprogesterone (FFNP), and 16β-[(18)F]fluoro-5α-dihydrotestosterone (FDHT), are important imaging tools for studies of breast and prostate cancers using positron emission tomography (PET). The automated production of these ligands with high specific activity (SA) as radiopharmaceuticals requires modification and optimization of the currently reported methods. [(18)F]FES with high SA was synthesized in over 60% radiochemical yield (RCY) at the end of synthesis (EOS) using a small amount of precursor (1) (as low as 0.3 mg) and 1 M H2SO4 for deprotection of the intermediate (2). [(18)F]FFNP was synthesized in up to 77% RCY at EOS using the triflate precursor (4) at room temperature or in 25% RCY using the mesylate precursor (6) at 65°C. Both methods are highly reproducible and afford high SA. [(18)F]FDHT was synthesized by radiofluoride incorporation at room temperature, reduction with NaBH4 , and deprotection with HCl/acetone, giving [(18)F]FDHT in up to 75% yield (RCY). All of these methods can be easily translated to automated production. The information provided here will aid in the development of automated production of these steroid receptor tracers with high or improved yields, optimal SA, and ease of processing for research and clinical use.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  FDHT; FES; FFNP; PET; radiopharmaceuticals; steroid receptor ligand

Mesh:

Substances:

Year:  2014        PMID: 24861984      PMCID: PMC4138509          DOI: 10.1002/jlcr.3191

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  32 in total

1.  Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.

Authors:  A Liu; K E Carlson; J A Katzenellenbogen
Journal:  J Med Chem       Date:  1992-05-29       Impact factor: 7.446

2.  A historical perspective on the specific activity of radiopharmaceuticals: what have we learned in the 35years of the ISRC?

Authors:  Suzanne E Lapi; Michael J Welch
Journal:  Nucl Med Biol       Date:  2013-01-26       Impact factor: 2.408

Review 3.  Molecular imaging of prostate cancer: PET radiotracers.

Authors:  Hossein Jadvar
Journal:  AJR Am J Roentgenol       Date:  2012-08       Impact factor: 3.959

4.  Bromine- and iodine-substituted 16alpha,17alpha-dioxolane progestins for breast tumor imaging and radiotherapy: synthesis and receptor binding affinity.

Authors:  Dong Zhou; Kathryn E Carlson; John A Katzenellenbogen; Michael J Welch
Journal:  J Med Chem       Date:  2006-07-27       Impact factor: 7.446

5.  Alternative synthesis for the preparation of 16α-[(18) F]fluoroestradiol.

Authors:  Hee Seup Kil; Han Yang Cho; Sang Ju Lee; Seung Jun Oh; Dae Yoon Chi
Journal:  J Labelled Comp Radiopharm       Date:  2013-07-09       Impact factor: 1.921

6.  Clinical production, stability studies and PET imaging with 16-alpha-[18F]fluoroestradiol ([18F]FES) in ER positive breast cancer patients.

Authors:  Piyush Kumar; John Mercer; Courtney Doerkson; Katia Tonkin; Alexander J B McEwan
Journal:  J Pharm Pharm Sci       Date:  2007       Impact factor: 2.327

7.  Automatic synthesis of 16 alpha-[(18)F]fluoro-17beta-estradiol using a cassette-type [(18)F]fluorodeoxyglucose synthesizer.

Authors:  Tetsuya Mori; Shingo Kasamatsu; Christoph Mosdzianowski; Michael J Welch; Yoshiharu Yonekura; Yasuhisa Fujibayashi
Journal:  Nucl Med Biol       Date:  2006-02       Impact factor: 2.408

8.  Predicting Breast Cancer Endocrine Responsiveness Using Molecular Imaging.

Authors:  Erin Currin; Hannah M Linden; David A Mankoff
Journal:  Curr Breast Cancer Rep       Date:  2011-12

Review 9.  PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.

Authors:  S D Jonson; M J Welch
Journal:  Q J Nucl Med       Date:  1998-03

10.  Synthesis of Clinical-Grade [(18)F]-Fluoroestradiol as a Surrogate PET Biomarker for the Evaluation of Estrogen Receptor-Targeting Therapeutic Drug.

Authors:  Manish Dixit; Jianfeng Shi; Ling Wei; George Afari; Sibaprasad Bhattacharyya
Journal:  Int J Mol Imaging       Date:  2013-05-09
View more
  10 in total

1.  Fully-automated synthesis of 16β-(18)F-fluoro-5α-dihydrotestosterone (FDHT) on the ELIXYS radiosynthesizer.

Authors:  Mark Lazari; Serge K Lyashchenko; Eva M Burnazi; Jason S Lewis; R Michael van Dam; Jennifer M Murphy
Journal:  Appl Radiat Isot       Date:  2015-05-21       Impact factor: 1.513

2.  18F-16α-17β-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer.

Authors:  Kelley Salem; Manoj Kumar; Ginny L Powers; Justin J Jeffery; Yongjun Yan; Aparna M Mahajan; Amy M Fowler
Journal:  Radiology       Date:  2017-09-25       Impact factor: 11.105

3.  Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.

Authors:  Szeman Ruby Chan; Amy M Fowler; Julie A Allen; Dong Zhou; Carmen S Dence; Terry L Sharp; Nicole M Fettig; Farrokh Dehdashti; John A Katzenellenbogen
Journal:  Clin Cancer Res       Date:  2014-12-17       Impact factor: 12.531

4.  Synthesis and in vivo evaluation of a radiofluorinated ketone body derivative.

Authors:  Stephanie J Mattingly; Melinda Wuest; Eugene J Fine; Ralf Schirrmacher; Frank Wuest
Journal:  RSC Med Chem       Date:  2020-02-13

5.  Ring opening of epoxides with [18F]FeF species to produce [18F]fluorohydrin PET imaging agents.

Authors:  Stefan Verhoog; Allen F Brooks; Wade P Winton; Benjamin L Viglianti; Melanie S Sanford; Peter J H Scott
Journal:  Chem Commun (Camb)       Date:  2019-05-30       Impact factor: 6.222

6.  Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.

Authors:  Kelley Salem; Manoj Kumar; Kyle C Kloepping; Ciara J Michel; Yongjun Yan; Amy M Fowler
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

7.  Fully automated synthesis of [(18) F]fluoro-dihydrotestosterone ([(18) F]FDHT) using the FlexLab module.

Authors:  Uwe Ackermann; Jason S Lewis; Kenneth Young; Michael J Morris; Andrew Weickhardt; Ian D Davis; Andrew M Scott
Journal:  J Labelled Comp Radiopharm       Date:  2016-07-04       Impact factor: 1.921

Review 8.  Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.

Authors:  Amy M Fowler; Amy S Clark; John A Katzenellenbogen; Hannah M Linden; Farrokh Dehdashti
Journal:  J Nucl Med       Date:  2016-02       Impact factor: 10.057

Review 9.  PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.

Authors:  John A Katzenellenbogen
Journal:  Cancers (Basel)       Date:  2020-07-23       Impact factor: 6.639

Review 10.  The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

Authors:  John A Katzenellenbogen
Journal:  Nucl Med Biol       Date:  2020-02-22       Impact factor: 2.408

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.